Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:24 AM
Ignite Modification Date:
2025-12-25 @ 12:24 AM
NCT ID:
NCT00098358
Eligibility Criteria:
Inclusion Criteria:
* Moderate to severe facial acne vulgaris
* 20 to 60 facial inflammatory lesions
* 10 to 200 facial non-inflammatory lesions
* No more than 3 facial nodular cystic lesions
Exclusion Criteria:
* Uncontrolled systemic disease
* Use of systemic or topical acne therapy within 14 days of study
* Use of systemic retinoids within past 2 years
* Skin diseases that interfere with acne counts
* Active liver disease
* Screening elevations in liver function tests
* Positive serology for hepatitis B or C
* Use of theophylline, warfarin, or propranolol within 7 days of study
* Use of Singulair or Accolate within 14 days of study
* Female patients who are pregnant or nursing
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Study:
NCT00098358
Study Brief:
Protocol Section:
NCT00098358